89 related articles for article (PubMed ID: 12503275)
1. [Conservative treatment of patients with stomach polyps].
Vakhrushev IaM; Kniazeva BG
Eksp Klin Gastroenterol; 2002; (4):44-6. PubMed ID: 12503275
[TBL] [Abstract][Full Text] [Related]
2. [The role of H2RA in the eradication therapy of Helicobacter pylori].
Yakabi K; Nakamura T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():676-82. PubMed ID: 11979869
[No Abstract] [Full Text] [Related]
3. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Popiela T; Kulig J; Karcz D; Tabor J; Torres J; Márquez M; Fillat O; Herrero E; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
[TBL] [Abstract][Full Text] [Related]
4. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
5. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Kume K; Hirakoba M; Murata I; Yoshikawa I; Otsuki M
Am J Gastroenterol; 2001 Sep; 96(9):2796-7. PubMed ID: 11569719
[No Abstract] [Full Text] [Related]
6. [The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection].
Petsch B; Kabala A; Pawłowski W
Pol Merkur Lekarski; 1998 Aug; 5(26):66-8. PubMed ID: 10101457
[TBL] [Abstract][Full Text] [Related]
7. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
[TBL] [Abstract][Full Text] [Related]
8. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy in complex treatment of ulcerous stenosis].
Rukhliada NV; Nazarov VE; Ermolaev IA
Vestn Khir Im I I Grek; 2003; 162(3):97-100. PubMed ID: 12942622
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
[TBL] [Abstract][Full Text] [Related]
12. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
13. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
14. [Management of the peptic ulcer patient in the Helicobacter pylori age].
Marshall BJ
Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
[No Abstract] [Full Text] [Related]
15. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
Ogura K; Hirata Y; Yanai A; Shibata W; Ohmae T; Mitsuno Y; Maeda S; Watabe H; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
Cisarò F; Astegiano M; De Angelis C; Saracco G; Rizzetto M; Pellicano R
Panminerva Med; 2011 Jun; 53(2):138. PubMed ID: 21659979
[No Abstract] [Full Text] [Related]
17. [Gastric hyperplastic polyp is one of the diseases for which H. pylori eradication is recommended].
Haruma K; Kamada T; Sugiu K; Tanaka A; Honda K
Nihon Rinsho; 2005 Nov; 63 Suppl 11():285-7. PubMed ID: 16363546
[No Abstract] [Full Text] [Related]
18. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
20. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
